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ABSTRACT
Objectives To prospectively evaluate an ultrasound-
based scoring system as a method for triaging asymp-
tomatic women presenting with an adnexal mass for
surgical treatment.
Methods Two hundred and four adnexal masses in 189
asymptomatic women undergoing elective surgical treat-
ment at our institution were included in this prospective
study. Patients were evaluated by transvaginal power
Doppler ultrasound imaging before surgery. Patients were
classified as low risk or high risk for malignancy accord-
ing to an ultrasound-based scoring system. Women with
a low risk for malignancy were scheduled for laparoscopy
and patients with a high risk for malignancy were sched-
uled for laparotomy. However, patients classified as low
risk by the ultrasound scoring system, but with a tumor
size ≥10 cm or clinical suspicion of pelvic adhesions,
were instead considered to be at intermediate risk and
were scheduled for laparotomy. Some patients classified
as high risk were scheduled for an operative laparoscopy
by an expert in gynecological oncology.
Results One hundred and thirty-four (65.7%) masses
were considered to be low risk and were treated by
a laparoscopically guided procedure. All these tumors
were benign. Forty-seven (23%) masses were classified as
high risk, of which 39 tumors were malignant and eight
benign. Twenty-three (11.3%) tumors were considered
to be intermediate risk and were scheduled for primary
laparotomy. In this group, 21 (91.3%) tumors proved to
be benign and two (8.7%) were malignant.
Conclusions Ultrasound-based triage of asymptomatic
women diagnosed with a persistent adnexal mass is
effective for selecting the surgical approach. Copyright
 2008 ISUOG. Published by John Wiley & Sons, Ltd.
INTRODUCTION
Women who present with pelvic masses commonly require
surgical intervention. Most of these masses are benign.
Laparoscopy has become the ‘gold standard’ in the
surgical management of benign adnexal masses because
this technique is associated with a lower morbidity and
involves a shorter hospital stay than does laparotomy1.
On the other hand, accurate surgical staging and
cytoreductive surgery have been shown to be among the
most important prognostic factors in ovarian cancer2.
Furthermore, it has been demonstrated that better
outcomes are achieved for ovarian cancer patients when
a gynecological oncologist performs this surgery3. For
these reasons, women presenting with suspicious adnexal
masses should be referred for primary laparotomy
to specialized centers for gynecological oncology with
experienced surgeons and adequate resources.
However, many patients with ovarian cancer are still
operated on in local non-specialized hospitals4. In many
cases this occurs because of an inaccurate preoperative
diagnosis. Therefore, an accurate preoperative diagnosis
is essential in order to establish the optimal management
in these patients.
Physical examination, serum CA 125 levels and
ultrasound examination have been used conventionally
for the differential diagnosis of adnexal masses. Physical
examination has been shown to be of limited value, even
under ideal conditions such as examination under general
anesthesia5. The use of CA 125 has also been limited
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because of its low positive predictive value (PPV) and low
sensitivity for early stages of ovarian cancer6.
Ultrasound imaging has been shown to be the best
diagnostic tool for differentiating malignant from benign
adnexal masses, with a sensitivity of around 90% and
a false-positive rate of about 25%7. For this reason,
ultrasound is considered as the first-line imaging technique
to be used when assessing an adnexal mass8.
In 2003 we published our ultrasound scoring system,
based on morphological and Doppler assessment, for
distinguishing between benign and malignant adnexal
masses9. The aim of the present study was to prospectively
evaluate this scoring system as a method for triaging
women presenting with an adnexal mass for surgical
treatment, laparoscopy or laparotomy.
METHODS
Over a 2-year period (June 2003 to June 2005),
189 asymptomatic women diagnosed with an adnexal
mass and undergoing elective surgical treatment at our
institution were included in this prospective study. Their
mean age was 40.7 (range, 15–73) years. One hundred
and forty-eight (78.3%) women were premenopausal and
41 (21.7%) were postmenopausal. Fifteen women had
bilateral masses, giving a total of 204 masses evaluated.
Our Institutional Review Board approved the study and
all women gave informed consent.
All patients were evaluated within 1 week before
surgery. Diagnostic work-up included a complete medical
history, physical examination and ultrasound exami-
nation. Medical history focused especially on patients’
complaints and past history that could raise the suspicion
of presence of pelvic adhesions, such as pelvic inflam-
matory disease (PID), pelvic endometriosis, peritonitis or
previous pelvic surgery.
Staff specialists in obstetrics and gynecology, three
of them specialized in gynecological oncology (J.L.A.,
M.J., G.L.G.), performed physical examinations in all
cases. Findings were reported as ‘inconclusive’ when no
reliable information could be obtained; ‘non-suspicious
for malignancy’ in the presence of an adnexal mass
with a maximum diameter of less than 8 cm, mobile
at examination, of cystic or solid consistency but with
regular contours and no evidence of ascites; or ‘suspicious
for malignancy’ in the presence of at least one of the
following: fixed and/or irregular adnexal mass regardless
of the size, maximum diameter > 8 cm and evidence of
ascites. Pelvic adhesions were suspected in the case of a
non-mobile mass that was fixed to the uterus or cul-de-sac,
and a past medical history of PID, pelvic endometriosis,
peritonitis or previous pelvic surgery.
The uterus and adnexal regions of all patients were
examined by transvaginal power Doppler ultrasonogra-
phy using a Voluson 730 (GE Healthcare Technologies,
Milwaukee, WI, USA). Special attention was paid to
adnexal masses. First, tumor size was calculated accord-
ing to maximum diameter. Then, morphological eval-
uation was performed with attention to the following
parameters10: bilaterality, wall thickness (thin <3 mm,
thick ≥ 3 mm), septations (not present, thin <3 mm,
thick ≥ 3 mm), papillary projections (not present, thin
<3 mm in length, thick ≥ 3 mm in length), solid areas (not
present, presence of any solid area ≥ 1 × 1 cm in internal
wall surface or septum) and ultrasound appearance (cys-
tic, anechogenic, homogeneous content, heterogeneous
content or mostly solid).
Following morphological evaluation, color Doppler
imaging was performed to identify vascular color signals
within the tumor. If blood flow was detected it was
reported as peripheral (color signals in the tumor wall or
periphery of a solid tumor) or central (blood flow detected
in septa, papillary projections, solid areas or central part
of a solid tumor). In tumors with both peripheral and
central blood flow, only central blood flow was used for
analysis.
Once a vessel had been identified by color Doppler
imaging, pulsed Doppler was used to obtain a flow
velocity waveform (FVW). Resistance index (RI = [S −
D]/S, where S and D are mean systolic and diastolic
velocities) and peak systolic velocity (PSV, cm/s) were
automatically calculated from at least three consecutive
FVWs. In those tumors with more than one vessel the
lowest RI and highest PSV found were used for analysis.
Tumors were classified into four velocimetric categories11:
low velocity/low resistance (PSV <10 cm/s, RI ≤ 0.45),
low velocity/high resistance (PSV <10 cm/s, RI >0.45),
high velocity/high resistance (PSV ≥ 10 cm/s, RI >0.45)
or high velocity/low resistance (PSV ≥ 10 cm/s, RI ≤ 0.45).
All premenopausal women were evaluated in the follicular
phase of the menstrual cycle.
We applied our scoring system9 to the findings
(Table 1). A score of ≥ 6 was considered to be suspicious
for malignancy. Patients were managed according to
the following protocol (Figure 1). Patients with adnexal
masses with a score <6 and <10 cm in size were
considered to be at low risk for malignancy and were
scheduled for laparoscopic surgery. Patients with adnexal
masses with a score <6, but with a maximum tumor
diameter ≥ 10 cm and/or suspicion of pelvic adhesions,
were considered to be at intermediate risk for cancer,
and were scheduled for laparotomy. Patients with adnexal
masses with an ultrasound score ≥ 6 were considered to be
at high risk for cancer and were scheduled for laparotomy.
In this group an abdominal ultrasound or computed
Table 1 Ultrasound-based scoring system for classification of
ovarian tumors
Score
Thick
papillary
projections
Solid
areas
Blood flow
location
Doppler
velocimetry
0 No No No flow or
peripheral
No flow/other
2 Yes — — High velocity/low
resistance
4 — Yes Central —
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Ultrasound and clinical assessment
Low risk
Low risk but with
tumor size ≥10 cm
or suspected adhesions
Suspicion of:
-MTS to ovary
-Stage I ovarian cancer
-Non-cytoreducible
 advanced-stage
 ovarian cancer
High risk
Operative
laparoscopyLaparotomy
Conventional
laparoscopy
Figure 1 Flow chart showing ultrasound-based triage for selecting surgical approach. MTS, metastasis.
tomography scan was performed in order to evaluate the
spread of disease. Some selected cases in this group (with
suspicion of metastases to the ovary, suspicion of non-
cytoreducible advanced-stage ovarian cancer, or suspicion
of small-sized early ovarian cancer) were ultimately
scheduled for advanced operative laparoscopy by an
expert in gynecological oncology.
In all cases tumors were surgically removed by
trained surgeons with more than 7 years’ experience
in laparoscopic surgery (J.L.A., M.J., G.L.G., J.A.M.,
M.G.M.), as well as more than 10 years’ experience in
gynecological oncological surgery (J.L.A., M.J., G.L.G.),
and definitive histological diagnoses were obtained.
Tumors were classified according to the World Health
Organization classification12. Ovarian malignancies were
staged according to the FIGO classification13. Tumors of
low malignant potential were considered to be malignant.
Qualitative variables were described as percentages and
compared using the Chi-square test. Continuous variables
were presented as median with range and compared
using the Mann–Whitney U-test. Sensitivity, specificity,
PPV, negative predictive value (NPV) and accuracy were
calculated for physical examination and the scoring
system. The McNemar test was used for comparing
sensitivity and specificity. P < 0.05 was considered
statistically significant. SPSS version 15.0 for Windows
(SPSS, Chicago, IL, USA) was used for statistical analysis.
RESULTS
Findings were considered suspicious for malignancy on
physical examination in 31 cases (15.2%). The ultrasound
score was ≥ 6 in 25 (81%) of these 31 cases.
After ultrasound examination, 134 (65.7%) masses in
123 women were considered to be low-risk tumors and
were scheduled for laparoscopy. In two of these women
laparoscopy was converted to laparotomy because of
pelvic adhesions. All tumors in this group proved to be
benign.
Twenty-three (11.3%) masses with an ultrasound score
of <6 were considered to be intermediate-risk tumors and
were scheduled for primary laparotomy owing to their
large size (≥ 10 cm; n = 15, 65.2%) or suspicion of pelvic
adhesions (n = 8, 34.8%). In this group, 21 (91.3%)
tumors were benign and two (8.7%) were malignant
(one Stage III ovarian cancer and one adenocarcinoma
of the appendix with metastases to the right ovary).
Both malignant tumors were large with no evidence of
metastatic disease and an ultrasound score <6 because of
the absence of blood flow. These results are summarized
in Figure 2.
Forty-seven (23%) masses in 43 women were consid-
ered to be high-risk tumors. In this group, 31 (72.1%)
patients (34 masses) were scheduled for primary laparo-
tomy. Thirty-three (97%) of these tumors were malig-
nant and one (3%) was benign (endometrioma). Twelve
(27.9%) women (13 masses) were scheduled for advanced
oncological laparoscopy because of suspicion of metas-
tases to the ovary (n = 2, 16.7%), non-cytoreducible
advanced ovarian cancer (n = 3, 25%) and early-stage
ovarian cancer (n = 7, 58.3%). Six (46.1%) of these
13 tumors were ultimately confirmed histologically as
malignant and seven (53.9%) were benign lesions (four
cystadenofibromas, one tubo-ovarian abscess, one der-
moid and one Brenner tumor).
The correlation between risk group and final histology
is shown in Table 2. Ultrasound features according to risk
group are shown in Table 3. Median tumor size in low-,
intermediate- and high-risk groups was 49 (range, 10–98)
mm, 110 (range, 40–238) mm and 72 (range, 21–270)
mm, respectively. Median tumor size was significantly
greater in the intermediate-risk than in the low-risk group
(P = 0.0001), and in the high-risk compared with the
low-risk group (P = 0.004). No significant difference was
found between the intermediate- and high-risk groups.
Physical examination was able to detect 76% of cases
of advanced ovarian cancer (19/25). However, it detected
only 4/10 cases of early-stage ovarian cancer and 2/6 cases
of metastatic cancer to the ovary. In benign tumors, the
Copyright  2008 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2008; 32: 220–225.
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Conversions n = 2
n = 34 n = 13
Masses n = 204
Low risk but with
tumors ≥10 cm or adhesions
n = 23
Low risk
n = 134
High risk
n = 47
Advanced
laparoscopyLaparotomyLaparotomy
Conventional
laparoscopy
Benign
n = 132
Malignant
n = 0
Benign
n = 21 + 2
Benign
n = 1
Benign
n = 7
Malignant
n = 2
Malignant
n = 33
Malignant
n = 6
Figure 2 Flow chart showing management of patients according to our ultrasound-based and clinical triage.
Table 2 Histology of the tumors according to risk classification
Tumor type
Low
risk (n)
Intermediate
risk (n)
High
risk (n)
Ovarian cancer Stage I 0 0 4
Ovarian cancer Stage II–IV 0 1 21
Low malignant potential tumor 0 0 8
Metastatic tumor 0 1 6
Endometrioma 56 4 1
Dermoid cyst 18 4 1
Serous cystadenoma 25 2 0
Mucinous cystadenoma 7 4 0
Hemorrhagic cyst 8 1 0
Hydrosalpinx 4 2 0
Cystadenofibroma 3 1 4
Tubo-ovarian abscess 0 0 1
Other benign tumor 13 3 1*
Total 134 23 47
Low risk: score < 6, maximum tumor diameter < 10 cm, no
suspicion of pelvic adhesions. Intermediate risk: score < 6 with
maximum tumor diameter ≥ 10 cm or suspicion of pelvic
adhesions. High risk: score ≥ 6. *One Brenner tumor.
findings on physical examination were non-suspicious in
157 (96%) cases. In six (3.7%) cases of benign tumor,
findings on physical examination were suspicious for
malignancy.
The sensitivity, specificity, PPV, NPV and accuracy
of physical examination in identifying malignant tumors
were 61%, 96%, 81%, 91% and 89%, respectively.
The positive likelihood ratio (LR+) for malignancy of
suspicious findings on physical examination was 16.7
(95% CI, 7.3–37.7) and the negative likelihood ratio
(LR−) was 0.41 (95% CI, 0.28–0.59).
Our ultrasound-based scoring system was able to detect
100% of early ovarian cancers, 96% of advanced ovarian
cancers and 87.5% of metastatic cancers to the ovary.
The sensitivity, specificity, PPV, NPV and accuracy of our
ultrasound-based scoring system were 95%, 95%, 83%,
99% and 95%, respectively. The LR+ for malignancy of
an ultrasound score ≥ 6 was 19.4 (95% CI, 9.8–38.2)
and the LR− was 0.05 (95% CI, 0.01–0.20). The scoring
system was significantly more sensitive than physical
examination (McNemar test, P = 0.004). No statistical
differences were found in specificity.
DISCUSSION
An accurate preoperative evaluation of adnexal masses
is essential in order to establish the optimal management
and appropriate referral of patients diagnosed with these
lesions. Physical examination has been shown to be of
limited value in detecting ovarian cancer, especially when
tumors are small or the patient obese5. Our results confirm
these data.
The differential diagnosis of adnexal masses has largely
relied on the use of ultrasound examination. The basis
of this technique is morphological characterization of
the tumor7. The role of pulsed Doppler imaging remains
controversial14. Some authors have advocated the use
of vessel location for reducing the false-positive rate
of B-mode morphological evaluation, with encouraging
results15.
A Medline search (1966–2006) identified only two
papers proposing and prospectively evaluating a protocol
for providing the best surgical approach for women
diagnosed with an adnexal mass. Berlanda et al. used
a complex algorithm based on a scoring system for
B-mode morphological characterization of the adnexal
mass16. If the score was <9 patients were considered to
be at low risk, and scheduled for laparoscopy. In masses
with a score ≥ 9, other factors, such as size ≥ 10 cm,
mobility, bilaterality, presence of ascites, serum CA 125
level ≥ 35 IU/mL and an intraovarian artery resistance
index ≤ 0.6, were taken into account. If at least one of
these features was present then the mass was considered
to be high risk and scheduled for laparotomy; those
Copyright  2008 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2008; 32: 220–225.
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Table 3 Sonographic features of the tumors according to risk classification
Feature
Low risk
(n = 134)
Intermediate risk
(n = 23)
High risk
(n = 47) P
Cyst wall < 0.001
Thin 124 (92.5) 15 (65.2) 18 (38.3)
Thick 10 (7.5) 8 (34.8) 29 (61.7)
Papillary projections < 0.001
None 123 (91.8) 21 (91.3) 20 (42.6)
Thin 5 (3.7) 1 (4.3) 0 (0)
Thick 6 (4.5) 1 (4.3) 27 (57.4)
Septations < 0.001
None 112 (83.6) 19 (82.6) 30 (63.9)
Thin 19 (14.2) 2 (8.7) 7 (14.9)
Thick 3 (2.2) 2 (8.7) 10 (21.3)
Solid areas < 0.001
None 115 (85.8) 15 (65.2) 12 (25.5)
Present 19 (14.2) 8 (34.8) 35 (74.5)
Echogenicity < 0.001
Cystic 110 (82.1) 13 (56.6) 2 (4.3)
Cystic–solid 19 (14.2) 5 (21.7) 28 (59.6)
Mostly solid 5 (3.7) 5 (21.7) 17 (36.2)
Blood flow < 0.001
None 59 (44) 7 (30.4) 2 (4.3)
Peripheral 71 (53) 13 (56.6) 2 (4.3)
Central 4 (3)* 3 (13) 43 (91.5)
Velocimetry < 0.001
Low velocity/high resistance 20 (26.7) 3 (18.8) 2 (4.4)
Low velocity/low resistance 9 (12) 5 (31.2) 1 (2.2)
High velocity/high resistance 42 (56) 7 (43.8) 12 (26.7)
High velocity/low resistance 4 (5.3) 1 (6.2) 30 (66.7)
Values are n (%). Low risk: score < 6, maximum tumor diameter < 10 cm, no suspicion of pelvic adhesions. Intermediate risk: score <6
with maximum tumor diameter ≥ 10 cm or suspicion of pelvic adhesions. High risk: score ≥ 6. *Central flow present in septations, not in
solid areas.
without any of these features were considered to be at
moderate risk. This approach provided 90% sensitivity,
97% specificity, 82% PPV and 99% NPV, with an overall
accuracy of 96%, in identifying malignant tumors as high
risk. The odds of malignancy in high-, moderate- and
low-risk groups were 4.5, 0.06 and 0.01, respectively.
Guerriero et al. proposed a simpler approach based on a
first-step B-mode morphological ultrasound evaluation17.
If the mass showed ‘typical benign findings’ such as
dermoid, endometrioma or serous cyst, women were
considered to be at very low risk and scheduled for
laparoscopy. In cases of evidence of metastatic disease,
large tumors (≥ 9 cm), presence of solid areas or ascites,
patients were considered to be at very high risk and
scheduled for laparotomy. Sensitivity, specificity, PPV
and NPV for this protocol were 100%, 91%, 95% and
100%, respectively. The odds of malignancy in the very
high-risk group were 3.55.
In our study, we propose an easy single-step ultrasound-
based protocol for triaging asymptomatic patients diag-
nosed with adnexal mass for laparoscopy or laparotomy.
Our protocol is based mainly on our morphological and
color Doppler ultrasound scoring system. As in previ-
ous studies, our intention was to classify patients into
low- and high-risk groups in order to select the most
appropriate surgical approach. We also took tumor size
and suspicion of pelvic adhesions into account in the
low-risk group. These two issues may limit laparoscopic
surgery. There is no established cut-off for tumor size
when choosing between laparoscopy and laparotomy,
although a maximum diameter of 10 cm seems to be a
reasonable limit18. On the other hand, it should be borne
in mind that the larger the tumor is the less accurate
ultrasound examination of the whole lesion might be.
Our scoring system provided good results, giving a
sensitivity, specificity, PPV, NPV and accuracy of 95%,
95%, 83%, 99% and 95%, respectively. These figures
are similar to those obtained by Berlanda et al.16 and
Guerriero et al.17, confirming that ultrasound-based triage
is an excellent method of selecting the surgical approach
for adnexal masses.
Bearing in mind that no protocol provides 100%
accuracy, when the tumor was <10 cm in maximum
diameter and the ultrasound score was < 6 in our study, no
malignancy was found on laparoscopic surgery. However,
when tumor size was ≥ 10 cm, two malignant tumors
were misclassified by our ultrasound scoring system as
benign (of 23 such cases in our series). This highlights
the limitations of an accurate ultrasound evaluation of
large tumors and implies that these tumors should be
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considered with caution. Similar conclusions were drawn
by Guerriero et al.17.
In spite of our efforts to achieve as accurate a
preoperative diagnosis as possible, some benign tumors
are still very difficult to discriminate from malignant
lesions. Our scoring system produced a 5% false-positive
rate in this prospective study. This figure lies between
the 3% previously reported by Berlanda et al.16 and
9% reported by Guerriero et al.17. This implies that,
when using B-mode and Doppler ultrasound triage, an
approximate false-positive rate of at least 5–10% has
to be assumed in discriminating benign from malignant
adnexal masses, even in experienced hands. In fact,
the results of the largest multicenter study applying an
ultrasound-based scoring system published so far reported
a false-positive rate of 24%18.
In conclusion, ultrasound-based triage of asymptomatic
women diagnosed with an adnexal mass is effective
for providing the most appropriate surgical approach,
permitting treatment of most benign tumors by a
laparoscopically guided procedure.
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